Seeing Is Believing
CRSP is currently covered by 21 analysts with an average price target of $74.94. This is a potential upside of $19.29 (34.66%) from yesterday's end of day stock price of $55.65.
Crispr Therapeutics AG's activity chart (see below) currently has 150 price targets and 175 ratings on display. The stock rating distribution of CRSP is 29.63% HOLD, 61.73% BUY and 8.64% SELL.
Analysts average stock forecasts to be materialized ratio is 65.47% with an average time for these price targets to be met of 99.04 days.
Highest price target for CRSP is $160, Lowest price target is $30, average price target is $74.94.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Apr-2024. First documented stock forecast 15-Nov-2016.
Currently out of the existing stock ratings of CRSP, 24 are a HOLD (29.63%), 50 are a BUY (61.73%), 7 are a SELL (8.64%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
89
$33.35 (59.93%)
70
7 days ago
11/16 (68.75%)
$32.84 (58.48%)
196
Buy
90
$34.35 (61.73%)
90
14 days ago
8/11 (72.73%)
$27.09 (43.06%)
214
Sell
48
$-7.65 (-13.75%)
42
1 months 30 days ago
3/6 (50%)
$-38.06 (-44.22%)
144
Hold
80
$24.35 (43.76%)
61
2 months 3 days ago
9/12 (75%)
$-6.19 (-7.18%)
109
Hold
66
$10.35 (18.60%)
57
2 months 3 days ago
6/8 (75%)
$-20.19 (-23.42%)
217
What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?
Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?
Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?